October 25, 2016 8:53 PM ET


Company Overview of Enanta Pharmaceuticals, Inc.

Executive Profile

Ernst-Günter Afting Ph.D., M.D.

Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee, Enanta Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 12 different industries.

See Board Relationships


Dr. Ernst-Günter Afting, Ph.D., M.D., served as the President and Chief Executive Officer of the National Research Center for Environment and Health, GSF-National Research Center for Environment and Health GmbH from 1995 to 2006. In addition, Dr. Afting is a Scientific Advisor to several pharmaceutical companies as well as to the Bavarian Ministry of Economic Affairs and Media, Energy and Technology. From 1993 to 1995, Dr. Afting served as President and Chief Executive ...

Corporate Headquarters

500 Arsenal Street
Watertown, Massachusetts 02472

United States

Phone: 617-607-0800
Fax: 617-607-0530

Board Members Memberships

Member of Board of Directors
Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee


University of Freiburg
University of Freiburg

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$51,375
Total Calculated Compensation$168,103

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Enanta Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.